Can a smartphone app ease the burden of feeding tube care?

NCT ID NCT07074301

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study will test whether a structured education program plus a mobile app can help caregivers of patients with a percutaneous endoscopic gastrostomy (PEG) tube. The goal is to improve caregivers' knowledge, reduce tube-related problems, and lessen their sense of burden. Eighty adult caregivers will take part, and the study will measure changes in knowledge and complication rates over two months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Caregiver Training Program and mobile application

What this could lead to

If it works, this could provide a simple, scalable way to improve home care for PEG tube patients and reduce caregiver stress.

What could go wrong

This is a small, early-stage study (80 participants) testing an educational tool, not a medical treatment. Results may not apply to all caregivers or settings.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CAREGIVER BURDEN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Caregiver Burden nutritional disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••